Company Overview of Restoragen Inc.
Restoragen, Inc. develops and produces recombinant peptide hormone therapies for age-related diseases. Its peptide therapies restore and regulate the body's endocrine hormone systems. The company’s products include hormone Glucagon-like peptide-1, which is used as a therapy for type II diabetes, obesity, glucose intolerance, and other metabolic conditions. Restoragen, Inc. also offers Growth Hormone Releasing Factor that stimulates the pituitary gland to release growth hormones for the treatment of osteoporosis, muscle frailty, and congestive heart failure. Restoragen, Inc. was formerly known as BioNebraska, Inc. The company was founded in 1989 and is headquartered in Lincoln, Nebraska.
5701 South 34th Street
Lincoln, NE 68516
Founded in 1989
Key Executives for Restoragen Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Restoragen Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.